EdgeMarket › Instruments › COCP

COCP — Cocrystal Pharma, Inc.

Name: COCP — Cocrystal Pharma, Inc. market data and filings
Creator: EdgeMarket

US Healthcare Pharma & biotech equity mkt cap 22.2M

1.15 -0.43% today

USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown

52w low 0.82 · high 1.58

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-03-12.

Performance

1 day-0.43%

1 week+2.68%

1 month+24.99%

3 months+1.77%

6 months+14.05%

Year to date+15.83%

1 year-24.34%

3 years-59.79%

5 years-90.70%

Technicals

RSI 1480.9

vs 50-day avg+14.50%

vs 200-day avg+6.07%

Volatility 1y77.5%

Max drawdown 1y-48.10%

Avg volume 30d66.7K

Daily bars held2,124

History from2018-03-12

Others in Healthcare

LLY +0.9%AKTX +1.6%JNJ +1.1%ONC +1.5%ABBV +1.2%MRK +2.4%UNH +1.4%NVS +1.7%

Insider transactions (Form 4)

date	insider	what	shares	price	value
2026-08-05	FROST PHILLIP MD ET AL Director	Open-market purchase	10.0K	0.98	9.8K
2026-08-03	FROST PHILLIP MD ET AL Director	Open-market purchase	75.0K	0.94	70.6K
2026-02-24	FROST PHILLIP MD ET AL Director	Open-market purchase	20.0K	1.00	20.0K
2026-02-06	FROST PHILLIP MD ET AL Director	Open-market purchase	50.0K	0.95	47.5K
2025-12-31	FROST PHILLIP MD ET AL Director	Open-market purchase	50.0K	0.95	47.5K
2025-12-30	FROST PHILLIP MD ET AL Director	Open-market purchase	20.0K	0.97	19.4K
2025-12-26	FROST PHILLIP MD ET AL Director	Open-market purchase	40.0K	0.97	38.8K
2025-12-24	FROST PHILLIP MD ET AL Director	Open-market purchase	25.0K	0.97	24.2K
2025-11-26	FROST PHILLIP MD ET AL Director	Open-market purchase	2.5K	0.99	2.5K
2025-11-26	FROST PHILLIP MD ET AL Director	Open-market purchase	1.5K	1.00	1.5K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

manager	value	shares
VANGUARD CAPITAL MANAGEMENT LLC	242.4K	240.0K
RENAISSANCE TECHNOLOGIES LLC	125.2K	123.9K
GEODE CAPITAL MANAGEMENT, LLC	91.1K	90.2K
BlackRock, Inc.	74.5K	73.7K
T3 Companies, LLC	52.0K	51.5K
XTX Topco Ltd	36.4K	36.0K
NEUBERGER BERMAN GROUP LLC	32.2K	31.9K
VANGUARD FIDUCIARY TRUST CO	24.3K	24.0K
STATE STREET CORP	20.7K	20.5K
TWO SIGMA SECURITIES, LLC	15.4K	15.3K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Short selling

Avg short volume, 90d35.3% of tape

Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Cocrystal Pharma, Inc. (COCP) filed form 8-K · 2026-08-18 · SEC EDGAR
Cocrystal Pharma, Inc. (COCP) filed form 8-K · 2026-08-17 · SEC EDGAR

Ask the AI about COCP

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open COCP in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Create a free account Open the terminal first

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →